Orchid Pharma Limited (ORCHPHARMA.NS) NSE

775.00

-7.75(-0.99%)

Updated at December 24 03:30PM

Currency In INR

Valuation

Market Cap39.71B
Enterprise Value41.24B
P/E Ratio75.12
PEG Ratio-1.94
Price/Sales Ratio4.79
Price/Book Ratio3.08
Enterprise/Revenue5.08
Enterprise/EBITDA41.02

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.09

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue9.22B
Revenue/Share162.14
Gross Profit3.55B
EBITDA1.45B
Net Income996.57M
Diluted EPS19.65

Balance Sheet

Total Cash1.5B
Total Cash/Share29.53
Total Debt2.82B
Total Debt/Equity0.22
Current Ratio3.35
Book Value Per Share251.49

Price History

52-Week Change-56.88
52-Week High1,997.4
52-Week Low603.8
Moving Average 50 Days800.63
Moving Average 200 Days759.96

Statistics

Average Volume101,483
Shares Outstanding50.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:218
Last Split DateJuly 25, 2019